Interestingly, three of the genes with the most common and penetrant ALS mutations known (TARDBP, FUS, and SOD1) depict drug targets, however, their interaction type is not categorized and thus they are not shown in the network (Figure 5). Here, SOD1 is linked to amyotrophic lateral sclerosis.